U.S.-approved mRNA flu shot may soon be in Canada. Here’s what one expert says

The first approval in the U.S. for a messenger RNA-based flu vaccine was signed off on by the U.S. Food and Drug Administration on Wednesday. The new vaccine, mFlusiva, will be available for adults aged 50 and older.

The Slatest A Better Flu Vaccine Is Possible, if Team RFK Jr. Stays Out of the Way Flu season is inevitable. This year’s could be better. Aug 06, 20265:44 PM Photo illustration by Slate. Photos by Anna Moneymaker/Getty Images and Joel Saget/AFP via Getty Images. This story is adapted from the Slatest newsletter. You ca

Two hurdles mRNA drugs face are a short half-life and impurities that trigger immune responses. Christoph Burgstedt/Science Photo Library via Getty Images Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was sti

Health Secretary Robert F. Kennedy Jr pulled $500 million in funding for mRNA vaccine development last year - the medical community said the U.S. would pay the price in dollars and lives